Abstract This paper looks at a case study involving BuckmanLaboratories and its pioneering use of knowledge management software and an intranet to help the company solve customer problems and generate sales.
From the Paper "Buckman has been a manufacturer of specialty chemicals for more than fifty years. Buckman coordinates the activities of twenty associate companies worldwide, has offices in more than eighty countries and sells more than ? specialty chemicals manufactured in eight factories. The Buckman family are the largest shareholders in this privately held company and Bob Buckman is the chairman and CEO."
Abstract This paper evaluates the primary components of a cytology laboratory. The author emphasizes the research personnel and the objectives sought with the research plan. The paper relates that a laboratory requires a team of individuals that work cooperatively to achieve a number of common goals, which necessitates the understanding of the organizational structure.
From the Paper "In any research-based environment, there is a strong necessity to provide research personnel with the tools and the space that is necessary to conduct effective inquiries into their area of interest. Therefore, a laboratory is a critical component of the research atmosphere, as it offers scientists the opportunity to conduct various studies and experiments that will potentially lead to new and exciting discoveries. In the field of cytology, the laboratory is the key component of all cell-based research, and it is necessary to provide adequate equipment, supplies, heating and cooling apparatus, and space to conduct this research effectively. However, there is another significant component to the laboratory, and this requires key personnel, individuals that are strongly committed to the research being performed within this space. A team effort is essential to develop the strongest research plan, to conduct the proposed experiments, to identify results and to draw valid conclusions."
Analyzes two books on the importance of scientist Louis Pasteur's laboratory work, ""Give Me a Laboratory and I Will Raise the World" (B. Latour) and "The Private Science of Louis Pasteur" (G. Geison).
1,150 words (approx. 4.6 pages), 2 sources, 2002, $ 44.95
Abstract In B. Latour's "Give Me a Laboratory and I Will Raise the World" and G. Geison's "The Private Science of Louis Pasteur" readers are given a glimpse into the laboratory practices of one of the icons of modern biological science. The two works share a vision of laboratory practice as central to the scientific method and, moreover, consider that the popular distinction between "inside" (the laboratory) and outside (the socio-political world) is both arbitrary and inaccurate. However, as this paper will argue, the two works differ radically when it comes to perspective. Geison's book is iconoclastic in that it interrogates the mythmaking process that he perceives as integral to Pasteur's laboratory work. Latour's chapter, on the other hand, may be seen as iconic for its militant defense of Pasteur's personality and practice as models of laboratory science to be adhered to in the present day.
This discusses the Structure-Conduct-Performance (SCP) of two multinational pharmaceutical companies, Abbott Laboratories and Baxter Corporation, in three markets with radical different health care systems, the U.S., Canadian, and Brazilian markets.
Abstract This paper evaluates a capitalistic market (the U.S.), a socialist/capitalistic market (Canada), and a developing market (Brazil), which can be broadly classified based on political, social, and cultural issues, to conceptually and practically understand the markets and the competition. The author points out that the generic pharmaceutical industry is flourishing in Canada; it accounts for approximately 15% of the sales of drugs in the country. The paper relates that, in Brazil, the major pharmaceutical industries are leveraging strongly on the government to change its laws and regulations in order to support better sales and distribution of the drug. Charts.
Table of Contents
Introduction
Background of the Study
Statement of the Problem
Purpose of the Study
Objectives of the Study
Limitations of Study
Definition of Terms
Literature Survey
Analysis of Factors Affecting the Pharmaceutical Company
Mergers, Acquisitions and Diversification in the Pharmaceutical Industry
History of Abbott Laboratories The SWOT Analysis for Abbott Laboratories Strengths of Abbott Laboratories Weaknesses of Abbott Laboratories Opportunity for Abbott Laboratories Threats faced by Abbott Laboratories History of Baxter Corporation
SWOT Analysis of Baxter Inc.
Strengths of Baxter
Weaknesses of Baxter
Opportunities Ahead for Baxter Inc.
Threats Facing Baxter
The U.S. Pharmaceutical and Healthcare Market
The Canadian Pharmaceutical and Healthcare Market
The Brazilian Pharmaceutical and Healthcare Market
Porter's Five-Force Framework for Analyzing the Pharmaceutical and Healthcare Industry
Internal Rivalry in the Global and U.S. Pharmaceutical/Healthcare Industry
Barriers to Entry
Substitutes and Complements
Buyer Power in the Different Markets of the U.S., Canada and Brazil
Bargaining Power of Suppliers
Marketing Theories
The Structure-Conduct-Performance Model for the Pharmaceutical Industry
Strategy and Nature of the Company's Business Level Strategy
External Factors Affecting the Pharmaceutical Industry
P.E.S.T.L.E. Analysis of the Pharmaceutical Industry in all Markets
Political Analysis
Economic Analysis
Social Analysis
Technology Analysis
Legal Environment
Environmental Analysis
Conclusion
From the Paper "Social science, economic, corporate and business strategy, public and government policies all are considered to play a significant role in the success or failure of an organization at any location around the world. In the modern marketplace, no fixed or definitive strategy can be assumed to be most effective. What may be appropriate for one company in the same industry may not exactly work for another company. Contemporary management theories place great emphasis on these variables; consequently, marketing strategies also use many of these theories to understand and evaluate the market for the product and services of the organization."
Abstract This paper provides an overview of Abbott Laboratories, a research-based, global pharmaceutical company that discovers, develops, manufactures and markets leading prescription medicines as well as many of the world's best known consumer healthcare products. The paper discusses the company's position in the industry, and the extent of it's global operations. It also analyzes the company's stock, with a risk and return and valuation analysis.
Table of Contents:
Introduction
Background of Abbott Laboratories & Operations
Competition Affecting Abbott's Stock Value
Risk & Return Analysis on Abbott Laboratories Stock
Summary of Financial Data
Du Pont Analysis of Abbott Laboratories Valuation & CAPM Analysis
Summary of Analysis
Conclusion
From the Paper "Abbott's business practices and goals have set the pace for the company's extraordinary portfolio management practices, security of the day to day management of resources, research, and development. Abbott has successfully overcome the uncertainty in drug development and competitive pressures. Abbott's business practices continue to make Abbott a unique company and has assisted the company to maintain its' global stance in the world of pharmaceutical companies.
"Everything done at Abbott Laboratories is a reflection of the company's mission, a commitment to serving the total health-care continuum. Abbott's stock analysis concludes with the fact that competitive pressures call for an unprecedented in-depth analysis monitoring of the company stock's general risk exposure."
Tags: performance, resources, research, development
Abstract This paper provides an overview of Charles River Laboratories and the biotechnology industry in which it competes. It describes current science challenges facing the company, economic and industry concerns and financial, marketing and ethical considerations. The paper then discusses relevant regulatory issues involved in the use of laboratory animals and legal and strategic planning issues for the company. Finally, the paper describes the company's current management and leadership cadre and discusses the challenges in its consulting and staffing services.
Table of Contents:
Review and Analysis
Company Overview
Science Challenges
Economic and Industry Concerns
Financial Considerations
Marketing Considerations
Ethical Considerations
Regulatory Issues
Legal Issues
Strategic Planning Issues
Management and Leadership
Challenges in Consulting and Staffing Services
Conclusion
From the Paper "The research showed that Charles River Laboratories is a Massachusetts-based company that was founded in 1947 and competes on a global basis today. The company provides products that have been shown to contribute in significant ways to the development of new drugs, including research models and their associated services. The research also showed that the company is subject to regulatory oversight from a wide range of national and international agencies, but has managed to not only comply with these regulations but has managed to effect substantive changes to them to their advantage over the years as well. The company has enjoyed a healthy economic performance, offset in part by recent changes in its accounting practices as described further in their latest annual report, but the bottom line outlook for Charles River Laboratories remains positive because the biotechnology industry is likewise expected to grow in exponential terms in the years to come. In sum, Charles River Laboratories is well positioned to take advantage of this explosive growth in the biotechnology field, and barring any unforeseen innovations in computer modeling applications for this purpose, demand for their products will likely continue to increase for the foreseeable future."
Abstract This paper looks at the evolution of the crime laboratory. Some of the advances in the last two decades have been: forensic photography and electronic imaging, fingerprints to DNA fingerprinting, ccounterfeit detection, toxicology, and CATCH software. All these have helped in advancing the fight against crime.
Abstract The paper gives a brief outline of the philosophical roots of enquiry into the human mind and the shift to 'scientifically valid' experimentation advocated by enlightenment scholars such as Descartes. The paper explores whether the conditions in laboratory experiments are artificial and, if so, does this affect the validity of results when applied to real world conditions.
From the Paper "As the study of the human mind shifted its focus from philosophical introspection to scientific enquiry problems of "confounding variables" arose contaminating certain aspects of psychological experiments. This led researchers to a shift the experiments into the laboratory, resulting in increasingly artificial and controlled conditions. Problems encountered when applying results from the laboratory to "real world" conditions are valid concerns that require consideration. In this essay I will give a brief outline of the history of the shift to laboratory-based experiments in psychology, examine the reasoning behind the increasingly controlled experimental conditions, discuss whether these conditions limit generalisability and consider the value of such experiments in defining aspects of human behaviour in "real world" conditions."
Abstract This paper presents the background of the company. The author points out the internal and external environments of Abbott Laboratories. The paper relates its strategies,organizational structure and past performance and predicts future performance..
From the Paper " A strategic audit was performed on Abbott Laboratories. Background information is presented on the company before the findings of the analyses are presented. The analyses included in the strategic audit of the company over the company's external environment, the company's internal environment, the strategies pursued by the company, the company'organizational structure and control systems, the company's past performance and predictions of the company's future performance. Abbott Laboratories began as a home-based business ..."
Abstract This paper examines the 2006 financial status of Abbott Laboratories based on an analysis of their liquidity, solvency, profitability and asset management ratios. These financial ratios show that Abbot has solid financial policies, despite a significant increase in short-term borrowings in 2006. The paper indicates that some of the ratios show that company profitability or asset utilization has decreased at Abbott from 2004 to 2006; however, this is most likely a short-term effect of the company's strategic reorganization to target its core business sectors and of the purchases and acquisitions that have not yet had the time to show their profitability. The paper includes formulas and chart.
From the Paper "In our opinion, it is not something to be concerned about, since the current ratio figure in 2006 is still around the value of 1, showing that the company currently has no difficulties in covering its short-term liabilities. Nevertheless, this is something that needs to be kept under observation in the subsequent period of time, so as not to become uncontrolled. The company's policies of reducing debts show that this is a priority under observation for the company's management."
Abstract More and more companies are considering the use of web-based training as a cost-effective alternative to traditional classroom-instruction. This paper provides a definition of WBT, before examining its advantages and the challenges facing this type of instruction. The paper then examines how WBT is applied in two real companies.
Paper Outline:
Definition of WBT
Importance of WBT
Advantages of WBT
Issues and Challenges
Real-World Applications of WBT
BuckmanLaboratories Siemens Business Communications Systems, Inc.
Bibliography
From the Paper "One downside of real-time technology, according to Fritz (1997), is the constant availability of an instructor, and scheduling WBT sessions so that the students and instructors are on-line at the same time. However, real-time, client server systems software, such as WBT Systems' Top Class, Network Publishing's N/able, and Centra Software's Symposium are a new breed of WBT development tools that are addressing problems associated with real-time technology. This new breed of software incorporates email messaging, discussion groups, and shared whiteboards to enhance communication."
Abstract This paper presents a brief history of W. Edward Deming and total quality management (TQM). It presents a review of quality and standard development and requirements, both nationally and internationally. The paper then discusses the implementation of TQM and Deming's fourteen guiding principles in the diagnostic medical environment. It hypothesizes that Deming's guiding principles can be effectively applied to the diagnostic medical laboratory environment. Finally, the paper examines International Standards Organization (ISO) standards used in the diagnostic laboratory setting and surveys from laboratories currently or recently implementing TQM into their environment.
Table of Contents:
Abstract
Key Words
Body of paper
Methodology
Literature Review
Deming and TQM
History
TQM
14 principles
Uniqueness of Diagnostic Laboratory Setting
Deming Applied to the Diagnostic Laboratory Conclusion
From the Paper "Libeer (13) tells us that as far back as 1981 Shewhart's control chart and TQM principles were used in clinical chemistry by Levey and Jennings, incorporating internal quality control and TQM principles from industry to the diagnostic medical laboratory. Libeer researched diagnostic medical laboratories on an international basis and found that in addition to ISO standards, most have their own proposed quality standards for medical laboratories but in order to compare them, using Deming's 'Plan-Do-Check-Adjust' approach is appropriate to assure quality elements are included, such as reagent and standards requirements."
Abstract This paper covers the history of the modern animal rights movement and examines and evaluates the current federal legislation regarding all aspects of animal testing and treatment of laboratory animals. Individual animal tests and alternatives to using laboratory animals are discussed from different viewpoints. Reasons for either supporting or condemning many different types of animal tests in the areas of medicine, cosmetics and scientific research are looked at.
From the Paper This paper covers the history of the modern animal rights movement and examines and evaluates the current federal legislation regarding all aspects of animal testing and treatment of laboratory animals. Individual animal tests and alternatives to using laboratory animals are discussed from different viewpoints. Reasons for either supporting or condemning many different types of animal tests in the areas of medicine, cosmetics and scientific research are looked at.
Abstract This paper takes a look at the goals set by "Fisher Scientific International" :Maintaining its leadership position in laboratory supplies and laboratory instruments, developing international markets, and increasing licensing and consulting associated with its technology division software products. These goals are then analyzed and the paper proceeds to discuss what needs to be done in order to achieve these strategic goals.
From the Paper "To accomplish there strategies Fisher must continue to make acquisitions to maintain or improve market share in the medical supplies, laboratory equipment, and chemicals businesses. Fisher has a head start over most of their competitors in the international arena. They must continue to invest in international infrastructure although it will take some time for this investment to impact Fisher's profits. The Technology division generates revenue with relatively little investment by the parent company. With the follow on consulting business for each licensee of their products, the opportunities for revenue and profit growth is better than in any of Fisher's core businesses. Fisher must continue to invest in its? software products to maintain its? lead by upgrading its? existing software products and developing new software products as needed."
This paper examines cinematic meaning through set design in the film "Mary Shelley's Frankenstein" (1931), directed by James Whale with the set design created by Charles D Hall and Hermann Rosse.
Abstract This paper explains that the set design interacts with all aspects of mis-en-scene, including the lighting of the film, the editing of the scenes, the portrayal of the characters and the movie's overall theme, to further exemplify the meaning of the film. The author points out that, in this "Frankenstein" (1931), the cluttered laboratory that forces top lighting for the close up of Dr. Frankenstein's face, which brings out his cheekbones, helps further the understanding of Dr. Frankenstein's insanity. The paper relates that, during the scene in which the monster comes alive, the backdrop in the tower also seems to come alive creating the theme of life as opposed to the whole set design of the eerie and slimy laboratory, which represents death.
From the Paper "In this particular film, the set design has a direct correlation with the themes of the movie. Not only does the set design bring out the themes of the movie, but also they help the viewer to bring the themes to a basic level. When the tower is first introduced during the storm, the lighting seen through the perfectly placed windows in the tower help bring out the theme of rage within Dr. Frankenstein. The whole theme of the movie is life and death and acting as god."
